# IDS-006_CLOSURE.md

## 1. Document Information

**Document:** IDS-006_CLOSURE.md
**Project:** 12-Gene Gastric Cancer Signature — Part 2: Modernized Biomarker Discovery Framework
**Closes:** IDS-006_Clinical_Translation_Implementation.md
**Governing documents:** PROJECT_GOVERNANCE_PROMPT_v4.5.1; FRAMEWORK_SPEC.md (LOCKED); IMPLEMENTATION_PHILOSOPHY_IDS_PHASE.md (LOCKED); IDS-001_Framework_Implementation.md (LOCKED); IDS-002_Discovery_Implementation.md (LOCKED); IDS-003_Modeling_Implementation.md (LOCKED); IDS-004_Validation_Benchmark_Implementation.md (LOCKED); IDS-005_Interpretability_Implementation.md (LOCKED); IDS-006_PREPARATION.md (LOCKED)
**Status:** LOCKED

---

## 2. Purpose

IDS-006_CLOSURE.md records the officially locked implementation specification for the Clinical Translation domain, as fixed in IDS-006_Clinical_Translation_Implementation.md. No additional implementation guidance, interpretation, or decision is introduced here. This is an immutable governance snapshot only.

---

## 3. Scope Locked

IDS-006 officially locked:

- Clinical Translation implementation responsibilities
- Clinical Translation domain decomposition
- Interpretability artifact consumption contract
- Clinical Translation Package contract
- Clinical risk representation responsibilities
- Clinical reporting responsibilities
- Clinical communication responsibilities
- Clinical decision-support packaging responsibilities
- Interpretability → Clinical Translation interface (consuming side)
- Clinical Translation dependency contract
- Clinical Translation verification contract
- Clinical Translation implementation boundaries

---

## 4. Locked Decisions

The following are now authoritative, as fixed in IDS-006:

- **Clinical Translation domain specialization** — IDS-006 specializes, without redefining, the framework-wide contracts established by IDS-001 and the Interpretability contracts established by IDS-005, scoped exclusively to the Clinical Translation implementation domain.
- **Internal implementation responsibilities** — Clinical Translation's contractual responsibilities correspond to the Clinical Translation responsibility already locked in FRAMEWORK_SPEC.md, treated as implementation responsibilities rather than a fixed coding-module decomposition.
- **One contractual purpose per Clinical Translation artifact** — the Clinical Translation Package is the single, authoritative contractual artifact of this domain.
- **Single producer requirement** — the Clinical Translation Package has exactly one producer, the Clinical Translation domain.
- **Read-only consumption of Interpretability artifacts** — Clinical Translation consumes Interpretability artifacts without modifying them; immutable artifact property and read-only contractual consumption are two distinct, explicit contractual guarantees, and consumption never transfers Interpretability's producer ownership to Clinical Translation.
- **No scientific interpretation within Clinical Translation** — scientific interpretation is completed exclusively within the Interpretability domain; Clinical Translation does not perform, repeat, or revisit it.
- **Clinical Translation produces new contractual artifacts** — Clinical Translation produces the Clinical Translation Package as a new, distinct artifact; Interpretability artifacts remain immutable throughout.
- **Preservation of complete contractual lineage** — every consumed Interpretability artifact remains contractually traceable through this domain; no Interpretation Package may disappear from contractual lineage.
- **Clinical Translation produces clinically consumable outputs only** — Clinical Translation does not generate new scientific evidence.
- **Clinical outputs are implementation responsibilities rather than contractual artifacts** — clinical risk representation, clinical reporting, clinical communication, and clinical decision-support packaging are responsibilities realized within the single Clinical Translation Package; none is an independent contractual artifact.
- **Contract-only verification philosophy** — verification under IDS-006 verifies implementation contracts, contractual completeness, contractual traceability, contractual interface compliance, and contractual lineage preservation; it does not verify scientific, biological, statistical, clinical, or methodological validity.

These decisions are recorded as locked; they are not reinterpreted here.

---

## 5. Inheritance

IDS-006 inherits, without redefinition, from IDS-001:

- Framework-wide Artifact Contracts
- Framework-wide Interface Contracts
- Framework-wide Dependency Contracts
- Framework-wide Verification Contracts

IDS-006 inherits, without redefinition, Interpretability contractual outputs from IDS-005.

---

## 6. Traceability

Every Clinical Translation implementation contract fixed in IDS-006 remains traceable to:

- FRAMEWORK_SPEC.md
- IMPLEMENTATION_PHILOSOPHY_IDS_PHASE.md
- IDS-001_Framework_Implementation.md
- IDS-005_Interpretability_Implementation.md

---

## 7. Governance Outcome

- IDS-006 is officially LOCKED.
- Future revisions require formal governance.
- Clinical Translation implementation is now governed by IDS-006.
- No implementation code is authorized by this document.

**Historical record (introduces no new governance decision):** with IDS-006 now LOCKED, the complete Framework-Level Implementation Architecture — IDS-001 through IDS-006 — is now complete.

---

## 8. Project Handoff

**Next governed activity:** IMPLEMENTATION_MASTER_PLAN.md

The IMPLEMENTATION_MASTER_PLAN will orchestrate the already locked IDS documents into an executable implementation roadmap. It shall introduce no new framework architecture and no new implementation contracts. Its responsibility is orchestration only.

IMPLEMENTATION_MASTER_PLAN.md itself is not generated as part of this closure.

---

**Status:** LOCKED — immutable. This document closes the entire IDS phase.
